Table 2 Summary of antibodies which can be used in differential diagnosis of ACA and SCC
From: Expression of HNF-1β in cervical carcinomas: an immunohistochemical study of 155 cases
ACA | SCC | |
|---|---|---|
HNF-1β | ++ | - |
(75%) | (2%) | |
p63/p40 | −+ | +++ |
(7% / 4%) | (100%) | |
CEA | +++ | +++ |
(86%) | (91%) | |
ER | +− | +− |
(16%) | (11%) | |
PR | −+ | - |
(9%) | (1%) | |
D2-40 | - | ++ |
(0%) | (54%) |